MENU
BPMUF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Basilea Pharmaceutica AG (BPMUF) Ownership - Who owns Basilea Pharmaceutica AG?
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections... Show more
Profile
Industry
N/A
Address
Hegenheimermattweg 167b
Phone
+41 616061111
Employees
147
Web
https://www.basilea.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
713.76M
P/E Ratio
9.79
Total Cash
128.37M
Projected Growth
N/A
Total Debt
96.79M
Revenue
236.21M
Risk (Beta)
0.42
Dividend Yield
N/A
Total Cash/Share
10.46
Total Debt/Equity
N/A
Revenue/Share
21.52 USD as % of share price
Fundamentals
BPMUF
Capitalization
714M
P/E Ratio
9.79
Risk (Beta)
0.42
Dividend Yield
N/A
Total Cash
128M
Total Cash/Share
10.46
Total Debt
96.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
21.52%
Revenue
236M
ROE
N/A
Book Value
103M
P/B Ratio
6.38
Cash Flow
N/A
Earnings
5.99
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
13.3M
Current Ratio
6.32
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
77.9M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
33.21
Shares Held By Institutions
202M
Shares Outstanding - Current
12.3M
Total Liabilities
146M
Total Volume MTD
N/A
Value
-1
Gain YTD
28.242
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Hegenheimermattweg 167b
Phone
+41 616061111
Employees
147
Web
https://www.basilea.com